Cancer screening with FDG-PET

被引:0
|
作者
Ide, M [1 ]
机构
[1] HIMEDIC Imaging Ctr Lake Yamanaka, Yamanashi 4010502, Japan
关键词
neoplasms; screening; fludeoxyglucose; positron emission tomography;
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Aim. Thi study is based on medical health check-up and cancer screening on of a medical health club using PET, MRI, spiral CT and other conventional examinations. Methods. Between October 1994 and June 2005, 9 357 asymptomatic members of the health club participated in 24 772 screening session (5 693 men and 3 664 women, mean age was 52.2 +/- 10.4 years). Results. Malignant tumors were discovered in 296 of the 9 357 participants (3.16%) and 24772 screening sessions (1.19%). The detection rate of our program is much higher than that of mass screening in Japan. The thyroid, lung, colon and breast cancers were PET positive, but the prostate, renal and bladder cancers were generally PET negative. Conclusion. FDG-PET has the potential to detect a wide variety of cancers at curable stages in asymptomatic Individuals. To reduce false-positive and false-negative results of PET examination, there is a need for experienced radiologist and/or oncologists who had training in the wide aspect of FDG-PET. FDG-PET has limitations in the detection of urological cancers, cancers of low cell density, small cancers and hypometabolic or FDG non-avid cancers. Therefore, conventional examinations and/or PET/CT are also needed for cancer screening in association with FDG-PET.
引用
收藏
页码:23 / 27
页数:5
相关论文
共 50 条
  • [1] Cancer screening by FDG-PET: benefit or risk?
    Jun Hatazawa
    [J]. Annals of Nuclear Medicine, 2011, 25 : 667 - 668
  • [2] Cancer screening by FDG-PET: benefit or risk?
    Hatazawa, Jun
    [J]. ANNALS OF NUCLEAR MEDICINE, 2011, 25 (09) : 667 - 668
  • [3] The usefulness of screening FDG-PET for breast cancer
    Otsuka, H.
    Toh, U.
    Fukushima, T.
    Fukunaga, M.
    Iwakuma, N.
    Shiruzu, K.
    [J]. EJC SUPPLEMENTS, 2010, 8 (03): : 243 - 243
  • [4] Screening for Cancer In Autoimmune Myopathies with FDG-PET/CT
    Maliha, P.
    Hudson, M.
    Abikzher, G.
    Probst, S.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S317 - S317
  • [5] FDG-PET and colon cancer
    Ken Miles
    [J]. Cancer Imaging, 2003, 3 (2) : 135 - 138
  • [6] FDG-PET in thyroid cancer
    Crippa, F
    Alessi, A
    Gerali, A
    Bombardieri, E
    [J]. TUMORI JOURNAL, 2003, 89 (05): : 540 - 543
  • [7] FDG-PET and endometrial cancer
    Kolesnikov-Gauthier, Helene
    Carpentier, Philippe
    [J]. BULLETIN DU CANCER, 2012, 99 (01) : 21 - 28
  • [8] Limitations of FDG-PET and FDG-PET With Computed Tomography for Detecting Synchronous Cancer in Pharyngeal Cancer
    Suzuki, Hidenori
    Hasegawa, Yasuhisa
    Terada, Akihiro
    Ogawa, Tetsuya
    Hyodo, Ikuo
    Suzuki, Masahiro
    Nakashima, Tsutomu
    Tamaki, Tsuneo
    Nishio, Masami
    [J]. ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2008, 134 (11) : 1191 - 1195
  • [9] Inter-observer variations in FDG-PET interpretation for cancer screening
    Suzuki, Akiko
    Nakamoto, Yuji
    Terauchi, Takashi
    Kawamoto, Masami
    Okumura, Yoshihiro
    Suzuki, Yutaka
    Sato, Toshihiko
    Takahashi, Nobukazu
    Lee, Jin
    Senda, Michio
    Uno, Kimiichi
    Inoue, Tomio
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2007, 37 (08) : 615 - 622
  • [10] FDG-PET and PET/CT in Colorectal Cancer
    Lonneux, Max
    [J]. PET CLINICS, 2008, 3 (02) : 147 - +